Hong Kong /

Hong Kong Economy

Banking & finance

The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs

A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.

China’s humanoid robot makers, Hong Kong start-ups set to dazzle CES 2026

videocam

Exclusive | HKMA teams up with SFC, Insurance Authority to promote fintech over next 5 years

The HKMA is expanding the city’s generative AI sandbox to include other industries, chief executive Eddie Yue Wai-man says.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW